HomeNewsScreenerChartsMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help

TKVA

Salspera Inc

Healthcare • Biotechnology • USA • NASD
Scroll to Statements
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand62.54M Perf Week-
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-
Enterprise Value- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-
Income- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-
Sales- P/B- EPS next Y- ROA- Short Interest- Perf YTD-
Book/sh-0.19 P/C- EPS next 5Y- ROE- 52W High- - Perf Year-
Cash/sh- P/FCF- EPS past 3/5Y-538.83% - ROIC- 52W Low- - Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility- - Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)- Perf 10Y-
Dividend Ex-Date- Quick Ratio5.85 Sales Y/Y TTM- Profit Margin- RSI (14)- Recom-
Dividend Gr. 3/5Y- - Current Ratio5.85 EPS Q/Q- SMA20- Beta- Target Price-
Payout- Debt/Eq- Sales Q/Q- SMA50- Rel Volume- Prev Close-
Employees2 LT Debt/Eq- Earnings- SMA200- Avg Volume- Price-
IPO- Option/ShortNo / No EPS/Sales Surpr.- - Trades Volume0 Change-
Salspera, Inc is a clinical-stage biotechnology company committed to developing novel therapies for solid tumor cancer. The company was founded on June 26, 2017 by Eddie Moradian and Daniel Saltzman and is headquartered in Cambridge, MA.
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)